• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在法国,哪些人有严重过敏反应的风险?

Who is at-risk for severe anaphylaxis in France?

作者信息

Tanno Luciana Kase, Luong Pham Thao Van, Dieval Megane, Dunoyer Caroline, Lawson Djito Tevi, Molinari Nicolas, Annesi-Maesano Isabella, Demoly Pascal

机构信息

Division of Allergy, Department of Pulmonology, Allergy and Thoracic Oncology, University Hospital of Montpellier, Montpellier, France.

Desbrest Institute of Epidemiology and Public Health, UMR UA11 University of Montpellier - INSERM, France.

出版信息

World Allergy Organ J. 2024 Sep 5;17(9):100951. doi: 10.1016/j.waojou.2024.100951. eCollection 2024 Sep.

DOI:10.1016/j.waojou.2024.100951
PMID:39295956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11408373/
Abstract

BACKGROUND

The understanding of risk factors related to severe anaphylaxis is key to implementing prevention strategies. We present the first French population-based nine-year anaphylaxis hospitalization study evaluating specific trends and factors related to severe anaphylaxis (SA), to support identification of phenotypes at-risk.

METHODS

This study used descriptive data from the French hospitalization database for the years 2012-2021, and included all patients hospitalized with anaphylaxis using International Classification of Diseases (ICD)-10 codes listed as a primary diagnosis. SA were cases that either required a hospitalization in intensive care units or resulted in death. Potential risk factors were identified according to corresponding ICD codes, available as secondary data during the patient's hospitalization.

RESULTS

The average hospitalization rate of all cases of anaphylaxis (SA and non-SA) was 1.34/100,000/year, and rate of admissions for SA was 0.08/100,000/year. Among the 5463 SA, 37.7% had unspecified coding label, when trigger was not identified. For SA cases in which trigger was identified, most were related to drugs (45.6%), followed by food (9.3%) and insect sting (7.2%). Overall, admissions due to anaphylaxis (SA and non-SA) were more frequent in males (57%). However, when the trigger was drugs, the proportion was significantly higher in females. For children aged 5-9 years, the most common trigger for SA was food. Patients for which SA was triggered by insect stings were identified exclusively in the 10-14 years age group. Chronic spontaneous urticaria was associated with insect sting-induced anaphylaxis, regardless of the severity. Angioedema was associated with all causes of SA. Cases of anaphylaxis presenting with urticaria and angioedema included cases with identified and unidentified triggers. Asthma and a personal history of allergy were associated with drug- and food-induced anaphylaxis.

CONCLUSION

This is the first study to provide data on severe phenotypes of anaphylaxis in France. Data presented is key to the implementation of public health actions and preventive strategies to improve quality care.

摘要

背景

了解与严重过敏反应相关的风险因素是实施预防策略的关键。我们开展了法国首个基于人群的为期九年的过敏反应住院研究,评估与严重过敏反应(SA)相关的特定趋势和因素,以支持识别高危表型。

方法

本研究使用了2012 - 2021年法国住院数据库中的描述性数据,纳入了所有以国际疾病分类(ICD)-10编码列为主要诊断而住院的过敏反应患者。SA是指那些需要入住重症监护病房或导致死亡的病例。潜在风险因素根据相应的ICD编码确定,这些编码在患者住院期间作为次要数据提供。

结果

所有过敏反应病例(SA和非SA)的平均住院率为1.34/100,000/年,SA的住院率为0.08/100,000/年。在5463例SA中,37.7%的病例编码标签未明确,即未识别出诱发因素。对于已识别出诱发因素的SA病例,大多数与药物有关(45.6%),其次是食物(9.3%)和昆虫叮咬(7.2%)。总体而言,过敏反应(SA和非SA)导致的住院在男性中更为常见(57%)。然而,当诱发因素是药物时,女性的比例显著更高。对于5 - 9岁的儿童,SA最常见的诱发因素是食物。仅在10 - 14岁年龄组中发现了由昆虫叮咬引发SA的患者。慢性自发性荨麻疹与昆虫叮咬诱发的过敏反应相关,无论严重程度如何。血管性水肿与所有SA病因相关。伴有荨麻疹和血管性水肿的过敏反应病例包括已识别和未识别诱发因素的病例。哮喘和个人过敏史与药物和食物诱发的过敏反应相关。

结论

这是第一项提供法国过敏反应严重表型数据的研究。所呈现的数据对于实施公共卫生行动和预防策略以改善优质护理至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a1c/11408373/5b6a09bd11e4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a1c/11408373/a130c88ad932/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a1c/11408373/5b6a09bd11e4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a1c/11408373/a130c88ad932/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a1c/11408373/5b6a09bd11e4/gr2.jpg

相似文献

1
Who is at-risk for severe anaphylaxis in France?在法国,哪些人有严重过敏反应的风险?
World Allergy Organ J. 2024 Sep 5;17(9):100951. doi: 10.1016/j.waojou.2024.100951. eCollection 2024 Sep.
2
Predictors of severe anaphylaxis in Hymenoptera venom allergy: The importance of absence of urticaria and angioedema.预测蜂类毒液过敏中严重过敏反应的因素:无荨麻疹和血管性水肿的重要性。
Ann Allergy Asthma Immunol. 2020 Jul;125(1):72-77. doi: 10.1016/j.anai.2020.03.007. Epub 2020 Mar 18.
3
Anaphylaxis in Brazil between 2011 and 2019.2011 年至 2019 年巴西的过敏反应。
Clin Exp Allergy. 2022 Sep;52(9):1071-1078. doi: 10.1111/cea.14193. Epub 2022 Jul 20.
4
Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012.过敏性反应相关住院病例增加,但死亡病例未增加:对1992 - 2012年英国全国过敏性反应数据的分析
J Allergy Clin Immunol. 2015 Apr;135(4):956-963.e1. doi: 10.1016/j.jaci.2014.10.021. Epub 2014 Nov 25.
5
Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).膜翅目昆虫毒液过敏的诊断与治疗:德国变态反应与临床免疫学会(DGAKI)与职业与环境皮肤病学会(ABD)、德国变态反应科医生协会(AeDA)、德国皮肤病学会(DDG)、德国耳鼻咽喉头颈外科学会(DGHNOKC)、德国儿科学与青少年医学学会(DGKJ)、儿童变态反应与环境医学学会(GPA)、德国呼吸学会(DGP)以及奥地利变态反应与免疫学会(ÖGAI)联合发布的S2k指南
Allergol Select. 2023 Oct 2;7:154-190. doi: 10.5414/ALX02430E. eCollection 2023.
6
Epidemiology of Anaphylaxis in Critically Ill Children in the United States and Canada.美国和加拿大危重病儿童过敏反应的流行病学。
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2241-2249. doi: 10.1016/j.jaip.2019.04.025. Epub 2019 Apr 30.
7
Epidemiological Data on Anaphylaxis in French Emergency Departments.法国急诊部门过敏反应的流行病学数据。
J Investig Allergol Clin Immunol. 2019;29(5):357-364. doi: 10.18176/jiaci.0348. Epub 2018 Nov 9.
8
Hospitalizations for Food-Induced Anaphylaxis Between 2016 and 2021: Population-Based Epidemiologic Study.2016 年至 2021 年食物诱导性过敏反应住院治疗情况:基于人群的流行病学研究。
JMIR Public Health Surveill. 2024 Aug 27;10:e57340. doi: 10.2196/57340.
9
Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema.重度蜂类毒液过敏反应中被高估和低估的参数:心血管药物和无荨麻疹/血管性水肿。
J Allergy Clin Immunol. 2012 Sep;130(3):698-704.e1. doi: 10.1016/j.jaci.2012.03.024. Epub 2012 May 1.
10
Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005.1993 - 1994年至2004 - 2005年澳大利亚过敏反应、血管性水肿和荨麻疹的住院趋势。
J Allergy Clin Immunol. 2007 Oct;120(4):878-84. doi: 10.1016/j.jaci.2007.07.040.

本文引用的文献

1
High burden of clonal mast cell disorders and hereditary α-tryptasemia in patients who need Hymenoptera venom immunotherapy.变应原免疫治疗患者中克隆性肥大细胞疾病和遗传性 α-胰蛋白酶血症负担高。
Allergy. 2024 Sep;79(9):2458-2469. doi: 10.1111/all.16084. Epub 2024 Mar 13.
2
Epidemiology of anaphylaxis: is the trend still going up?过敏反应的流行病学:趋势仍在上升吗?
Curr Opin Allergy Clin Immunol. 2023 Oct 1;23(5):349-356. doi: 10.1097/ACI.0000000000000933. Epub 2023 Aug 2.
3
Fatal and near-fatal anaphylaxis: The Allergy-Vigilance® Network data (2002-2020).
致命性和接近致命性过敏反应:过敏监测网络数据(2002-2020 年)。
Allergy. 2023 Jun;78(6):1628-1638. doi: 10.1111/all.15645. Epub 2023 Jan 24.
4
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths.全球药物过敏致死模式:预防可避免死亡的警钟。
Curr Opin Allergy Clin Immunol. 2022 Aug 1;22(4):215-220. doi: 10.1097/ACI.0000000000000835.
5
Risk factors for severe reactions in food allergy: Rapid evidence review with meta-analysis.食物过敏严重反应的危险因素:快速证据综述与荟萃分析。
Allergy. 2022 Sep;77(9):2634-2652. doi: 10.1111/all.15318. Epub 2022 Apr 28.
6
Risk Factors in Severe Anaphylaxis: Which Matters the Most, Food or Cofactors?严重过敏反应的危险因素:食物还是共因素更重要?
J Investig Allergol Clin Immunol. 2022 Jul 22;32(4):282-290. doi: 10.18176/jiaci.0698. Epub 2021 May 4.
7
EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma.欧洲变态反应和临床免疫学会(EAACI)关于过敏和哮喘青少年及青年有效过渡的指南。
Allergy. 2020 Nov;75(11):2734-2752. doi: 10.1111/all.14459. Epub 2020 Jul 21.
8
Global Trends in Anaphylaxis Epidemiology and Clinical Implications.全球过敏反应流行病学趋势及其临床意义。
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1169-1176. doi: 10.1016/j.jaip.2019.11.027. Epub 2019 Nov 28.
9
Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases-11.通过世界卫生组织的《国际疾病分类-11》改变过敏反应死亡率统计数据的历史。
J Allergy Clin Immunol. 2019 Sep;144(3):627-633. doi: 10.1016/j.jaci.2019.05.013. Epub 2019 Jun 20.
10
Drug Hypersensitivity Reactions Documented in Electronic Health Records within a Large Health System.大型医疗体系中电子健康记录中的药物过敏反应文档。
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1253-1260.e3. doi: 10.1016/j.jaip.2018.11.023. Epub 2018 Dec 1.